220 related articles for article (PubMed ID: 11449371)
1. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
[TBL] [Abstract][Full Text] [Related]
2. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
[TBL] [Abstract][Full Text] [Related]
3. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
4. The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
Menten P; Struyf S; Schutyser E; Wuyts A; De Clercq E; Schols D; Proost P; Van Damme J
J Clin Invest; 1999 Aug; 104(4):R1-5. PubMed ID: 10449444
[TBL] [Abstract][Full Text] [Related]
5. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity.
Nibbs RJ; Yang J; Landau NR; Mao JH; Graham GJ
J Biol Chem; 1999 Jun; 274(25):17478-83. PubMed ID: 10364178
[TBL] [Abstract][Full Text] [Related]
6. Macrophage inflammatory protein-1.
Menten P; Wuyts A; Van Damme J
Cytokine Growth Factor Rev; 2002 Dec; 13(6):455-81. PubMed ID: 12401480
[TBL] [Abstract][Full Text] [Related]
7. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
8. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.
Struyf S; De Meester I; Scharpé S; Lenaerts JP; Menten P; Wang JM; Proost P; Van Damme J
Eur J Immunol; 1998 Apr; 28(4):1262-71. PubMed ID: 9565366
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-HIV-1 activity of CC-chemokine LD78beta, a non-allelic variant of MIP-1alpha/LD78alpha.
Xin X; Shioda T; Kato A; Liu H; Sakai Y; Nagai Y
FEBS Lett; 1999 Aug; 457(2):219-22. PubMed ID: 10471782
[TBL] [Abstract][Full Text] [Related]
10. Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases.
Ryu OH; Choi SJ; Firatli E; Choi SW; Hart PS; Shen RF; Wang G; Wu WW; Hart TC
J Biol Chem; 2005 Apr; 280(17):17415-21. PubMed ID: 15728180
[TBL] [Abstract][Full Text] [Related]
11. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
Pease JE; Wang J; Ponath PD; Murphy PM
J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
[TBL] [Abstract][Full Text] [Related]
14. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
15. Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter.
Phillips RM; Stubbs VE; Henson MR; Williams TJ; Pease JE; Sabroe I
J Immunol; 2003 Jun; 170(12):6190-201. PubMed ID: 12794150
[TBL] [Abstract][Full Text] [Related]
16. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
17. Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication.
Miyakawa T; Obaru K; Maeda K; Harada S; Mitsuya H
J Biol Chem; 2002 Feb; 277(7):4649-55. PubMed ID: 11734558
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
[TBL] [Abstract][Full Text] [Related]
20. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells.
Tiffany HL; Alkhatib G; Combadiere C; Berger EA; Murphy PM
J Immunol; 1998 Feb; 160(3):1385-92. PubMed ID: 9570558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
